pakman schreef op 9 november 2021 17:13:
[...]
Moderna Files to Expand the Conditional Marketing Authorization for its COVID-19 Vaccine in the European Union to Include Children Ages 6-11 Years
Submission based on Phase 2/3 study of mRNA-1273 in children ages 6 to 11
November 09, 2021 08:32 AM Eastern Standard Time
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Moderna Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that it has submitted for a variation to the conditional marketing authorization (CMA) with the European Medicines Agency (EMA) for the evaluation of a 50 µg two-dose series of mRNA-12731 in children ages 6-11 years.
toch maar ff wachten